Acrivon Therapeutics, Inc. - COMMON STOCK (ACRV)

Historical Portfolio Holders from Q4 2022 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COMMON STOCK
Shares, excl. options Q1 2024
15.2 M
Holdings value Q1 2024
$109 M
Value change Q1 2024
+$3.39 M
Grand Portfolio weight change Q1 2024
+0%
Number of holders
44
Number of buys Q1 2024
0
Number of sells Q1 2024
0
Average buys Q1 2024 %
0
Average sells Q1 2024 %
0
CUSIP
004890109
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 15.2 M $109 M +$3.39 M $7.15 44
2023 Q4 14.9 M $73.1 M +$986 K $4.92 40
2023 Q3 15.1 M $144 M -$326 K $9.56 43
2023 Q2 15.1 M $196 M -$1.15 M $12.96 40
2023 Q1 15.2 M $191 M +$6.82 M $12.69 39
2022 Q4 15 M $170 M +$170 M $11.52 18